Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody
Rui Feng(Chinese Academy of Sciences), Ling Zhu(Institute of Genetics), Hai Hou(Northwestern Polytechnical University), Kang Wang(Fujian Medical University), Dawei Shi(National Institutes for Food and Drug Control), Xiangxi Wang(Peking University), Binyang Zheng(Chinese Academy of Sciences), Deju Xia(National Institutes for Food and Drug Control), Li Zhang(Beijing Red Cross Blood Center), Lei Wang(Tang Hospital), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Sihong Xu(National Institutes for Food and Drug Control)
Cited by 3
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
Versatile applications of capacitive deionization (CDI)-based technologies
|Desalination|2020|316
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204